Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Kiara Mohamed Amin

67 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
https://openalex.org/A5092443744

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.Molecular Psychiatry · 2026-07-06Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-04-30Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under PsilocybinUnknown journal · 2026-04-07Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compoundsJournal of Psychopharmacology · 2026-02-04Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews · 2026-01-23The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysisBMC Psychology · 2026-01-01Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-12-08Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case ReportDOAJ (DOAJ: Directory of Open Access Journals) · 2025-11-30Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-11-20Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping ReviewPreprints.org · 2025-10-16Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialPLoS Medicine · 2025-09-18“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autismMagna Scientia Advanced Research and Reviews · 2025-06-27The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-04-30Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-24Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg s Archives of Pharmacology · 2025-04-14Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-02-24Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Unknown journal · 2025-02-23Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDiJournal of the American Society for Mass Spectrometry · 2025-02-02What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?Cochrane Clinical Answers · 2025-01-12Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case reportPalliative & Supportive Care · 2024-12-31Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04Impact of psilocybin on cognitive function: A systematic review.Unknown journal · 2024-09-30Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant responseJournal of Psychopharmacology · 2024-09-19Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish AdultsResearch Square · 2024-08-14Psilocybin legislation is helping psychedelic drugs make a comeback - a drug researcher explains the challenges they faceUnknown journal · 2024-08-01Psilocybin desynchronizes the human brainNature · 2024-07-16Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse IndicationsDrug and Alcohol Dependence · 2024-06-30The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.Journal of psychopharmacology (Oxford, England) · 2024-04-30Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-04-30Mechanisms of therapeutic change after psychedelic treatment in OCDPsychiatry Research · 2024-04-06Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisCancer · 2023-12-17The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.Unknown journal · 2023-10-29Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSDJournal of Psychoactive Drugs · 2023-08-30Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapyJournal of Psychedelic Studies · 2023-08-20On the mushrooming reports of “quiet quitting”: Employees’ lifetime psilocybin use predicts their overtime hours workedJournal of Psychoactive Drugs · 2023-07-30Trip Where you Stand: Towards Psychedelic LiberationFeminist Review · 2023-06-30HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerJournal of Pain and Symptom Management · 2023-06-09Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trialJournal of Psychedelic Studies · 2023-01-17Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeismJournal of Psychedelic Studies · 2023-01-15A Review of Synthetic Access to Therapeutic Compounds Extracted from.Pharmaceuticals (Basel, Switzerland) · 2022-12-27Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case reportHeliyon · 2022-11-30Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)Journal of Anesthesiology and Pain Therapy · 2022-10-02Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.The International Journal of Neuropsychopharmacology · 2022-03-31Counselors’ attitudes toward psychedelics and their use in therapyJournal of Counseling & Development · 2022-03-18Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.Translational Psychiatry · 2022-02-22Is MDD the right target for early-stage psychedelic-assisted therapy trials?Journal of Psychedelic Studies · 2021-09-14Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in Psychiatry · 2021-08-05Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.Journal of psychiatric research · 2021-04-30Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of Clinical Psychopharmacology · 2021-04-30[Efficacy of psychedelics in psychiatry, a systematic review of the literature].Unknown journal · 2021-04-19A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.PubMed · 2020-12-31Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman LanguageJournal of Posthuman Studies · 2020-11-30Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.Journal of psychopharmacology (Oxford, England) · 2020-09-30These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstopAccess Science · 2018-12-31Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOIPsychopharmacology · 2008-07-04Persistent psychiatric symptoms after eating psilocybin mushrooms.Unknown journal · 1979-04-30[Studies on hallucinogens. V. Synthesis of psilocybin].Unknown journal · 1973-12-31[Studies on hallucinogens. 3. Synthesis of psilocin (author's transl)].Unknown journal · 1972-12-31

Author directory

Carhart-Harris RL.59 publicationsRobin Carhart-Harris57 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ50 publicationsJohnson MW44 publicationsErritzoe D43 publicationsRoseman L41 publicationsBarrett FS.34 publicationsDavid Erritzøe34 publicationsDavid Nutt34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsRoland R. Griffiths28 publicationsHendricks PS27 publicationsFranz X. Vollenweider24 publicationsGitte M. Knudsen24 publicationsRosenblat JD24 publicationsGarcia-Romeu A23 publicationsKatrin H. Preller23 publicationsAlbert Garcia-Romeu22 publicationsPatrick M. Fisher22 publicationsPáleníček T.22 publicationsSandeep M. Nayak22 publicationsTomáš Páleníček22 publicationsDea Siggaard Stenbæk21 publicationsFisher PM21 publicationsMatthew W. Johnson21 publicationsDavis AK20 publicationsFrederick S. Barrett20 publicationsMcIntyre RS20 publicationsJames Rucker19 publicationsKargbo RB.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDirk Hoffmeister18 publicationsDos Santos RG18 publicationsHusain MI18 publicationsLiechti ME18 publicationsM. Madsen18 publicationsNathan D. Sepeda18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsGuy M. Goodwin17 publicationsKuypers KPC.17 publicationsSimonsson O17 publicationsBrice Ozenne16 publicationsHannes Kettner16 publicationsKringelbach ML.16 publicationsKwan AC.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsYale University16 publicationsFischer R.15 publicationsGonzález-Maeso J15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsMadsen MK15 publicationsMason NL.15 publicationsMatthias E. Liechti15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsAlan K. Davis14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKim P. C. Kuypers14 publicationsKometer M14 publicationsManish Agrawal14 publicationsMuhammad Ishrat Husain14 publicationsNayak SM14 publicationsBasel13 publicationsDavid J. Hellerstein13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsNatasha L. Mason13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsDavid B. Yaden12 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJoshua Woolley12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMartin Kuchař12 publicationsMcCulloch DE12 publicationsPeter S. Hendricks12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsStephen Ross12 publicationsWang X12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsAlexander M. Sherwood11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsFriederike Holze11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsKaelen M11 publicationsLeor Roseman11 publicationsMichael P. Bogenschutz11 publicationsNichols CD.11 publicationsOsika W11 publicationsRoger S. McIntyre11 publicationsScott T. Aaronson11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsCharles D. Nichols10 publicationsChristopher Timmermann10 publicationsDavoudian PA10 publicationsDrummond E-Wen McCulloch10 publications